ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,071Medicare Part D Prescriptions Filled, Including Refills

Rank: 142 out of 5176

$1.16M Total Retail Price of All Prescriptions

Rank: 183 out of 5176

685 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 685 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 685 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 16,052 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
OMEPRAZOLE 716 631 1 3
SIMVASTATIN 687 615 2 1
LISINOPRIL 681 573 3 5
FUROSEMIDE 608 576 4 8
METOPROLOL TARTRATE 516 462 5 6
METOPROLOL SUCCINATE 504 486 6 11
LEVOTHYROXINE SODIUM 502 451 7 4
HYDROCODONE-ACETAMINOPHEN 408 299 S3 8 27
AMLODIPINE BESYLATE 407 350 9 2
ATORVASTATIN CALCIUM 316 299 10 9
PREDNISONE 304 259 11 52
WARFARIN SODIUM 277 261 12 13
RAMIPRIL 244 235 13 50
METFORMIN HCL 240 210 14 7
TAMSULOSIN HCL 235 222 15 20
CRESTOR 205 190 16 15
DONEPEZIL HCL 202 195 17 28
HYDROCHLOROTHIAZIDE 200 180 18 10
ISOSORBIDE MONONITRATE ER 198 196 19 44
LOSARTAN POTASSIUM 195 179 20 14
ALENDRONATE SODIUM 189 189 21 18
CITALOPRAM HBR 186 157 22 31
AZITHROMYCIN 184 166 23 42
KLOR-CON M20 179 163 24 129
ALLOPURINOL 176 173 25 41
ATENOLOL 159 158 26 12
NAMENDA 153 150 27 47
NEXIUM 145 129 28 16
PLAVIX 137 132 29 29
ADVAIR DISKUS 137 109 29 32
GABAPENTIN 132 102 31 21
CIPROFLOXACIN HCL 122 114 32 84
SERTRALINE HCL 120 106 33 30
VENTOLIN HFA 120 89 33 64
PRAVASTATIN SODIUM 117 110 35 23
CLOPIDOGREL 115 115 36 26
CLOTRIMAZOLE-BETAMETHASONE 113 92 37 94
JANUVIA 111 108 38 25
FINASTERIDE 110 108 39 69
RANITIDINE HCL 108 103 40 36
CARVEDILOL 105 94 41 24
GLYBURIDE-METFORMIN HCL 101 84 R 42 76
LEVOFLOXACIN 100 76 43 109
ESCITALOPRAM OXALATE 99 89 44 89
PAROXETINE HCL 98 83 45 93
DIOVAN 98 90 45 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 68 47 49
DIGOXIN 87 79 48 56
LANSOPRAZOLE 86 67 49 113
SYNTHROID 84 76 50 33
GLIPIZIDE ER 84 82 50 117
ONGLYZA 84 73 50 153
OXYBUTYNIN CHLORIDE ER 77 73 53 204
MELOXICAM 77 68 53 53
LOSARTAN-HYDROCHLOROTHIAZIDE 75 64 55 35
POTASSIUM CHLORIDE 75 75 55 34
GLIPIZIDE 72 72 57 63
CARBIDOPA-LEVODOPA 71 71 58 98
AMITRIPTYLINE HCL 71 46 R 58 177
DIOVAN HCT 71 71 58 39
PANTOPRAZOLE SODIUM 69 66 61 61
BUSPIRONE HCL 68 66 62 183
QUETIAPINE FUMARATE 68 48 62 75
CELEBREX 67 57 64 80
TRAMADOL HCL 65 58 65 40
FLUTICASONE PROPIONATE 65 59 65 38
SEROQUEL 64 53 67 166
LYRICA 64 56 67 133
SPIRIVA 62 52 69 54
LANTUS 61 58 70 66
PROAIR HFA 61 51 70 60
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 43 72 181
CYMBALTA 60 40 72 90
EVISTA 58 58 74 65
COMBIVENT 56 26 75 156
TRAZODONE HCL 56 53 75 71
PROPRANOLOL HCL 55 52 77 199
VENLAFAXINE HCL ER 54 42 78 186
DILTIAZEM 24HR ER 54 34 78 136
SYMBICORT 53 34 80 120
ZETIA 52 51 81 68
ROPINIROLE HCL 52 44 81 208
GLYBURIDE 52 50 R 81 67
NASONEX 51 40 84 178
MIRTAZAPINE 51 46 84 45
FENTANYL 51 38 S2 84 172
LEVETIRACETAM 50 38 87 92
KLOR-CON 10 50 40 87 225
GLIMEPIRIDE 50 50 87 37
CLONIDINE HCL 50 29 87 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.